Oxygen Biotherapeutics – Employing Oxygen, Preserving Life!

Brain Injury

OXYCYTE™ as
a treatment
for TBI

Defense Medicine

OXYCYTE, Battlefield Injuries, and Purple Heart Injury Laboratories

Topical indications

OXYCYTE™ in Wound Care
and Cosmetic Uses

NEWS
November 17, 2009 Oxygen Biotherapeutics, Inc. today announced that the company has begun shipping Dermacyte™ Oxygen Concentrate Gel to customers who have pre-ordered through the BuyDermacyte.com website.

Quick Links

>> TBI Phase II Clinical Trial Status
>> Company Videos
>> Latest News
>> Chairman's Blog

Events

Oxygen Biotherapeutics, Inc. held a shareholders meeting on Oct. 19, 2009. A replay of the webcast of that meeting may be found in the investor relations section of this website.

Interview with Chris Stern CEO

Chairman and CEO Chris Stern talks about shipping Dermacyte orders in this video.